Stocks › ONC
BeOne Medicines Ltd. (ONC) stock analysis
SKIP 6% confidence · analysed Nov 4, 2026
On Nov 4, 2026, our model rated BeOne Medicines Ltd. (ONC) SKIP with 6% confidence at a price of $355.00. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 52, close to the neutral 50 line, so momentum is balanced.
MACD is below its signal line, so short-term momentum is pointing down.
The price has slipped below its 50-day moving average but is still above the 200-day: a pullback inside a longer-term uptrend.
Volume is about normal (1.3x the 20-day average).
Trend structure and money flow
Market structure shows a bullish change of character (CHoCH): the first break against the prevailing trend, an early hint of a possible reversal.
The most recent swing high is $328.39 and the swing low is $253.95; traders often treat these as resistance and support.
Fundamentals
The PEG ratio is 0.75, which looks cheap relative to its expected growth.
The company reports a profit margin of 10.7% and revenue growth of +29.6%.
In its latest quarter it earned $2.05 per share, which beat the $1.63 analysts expected, with revenue +29.6% year over year.
Wall Street's average rating is 1.3 on a 1 (strong buy) to 5 (sell) scale, roughly a "strong buy", with an average price target of $437.57.
The next earnings report is expected around Nov 5, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score -0.06 (SKIP). Technicals: RSI 51.93, MACD bearish, price below SMA50. Fundamentals: PEG 0.75, margin 10.7%, revenue growth 29.6%. Financial results: YoY revenue +29.6%, last EPS surprise +25.8%, next earnings 2026-11-05. Smart Money Concepts: CHoCH bullish (possible trend reversal up). FinGPT news read: positive. Reference price $355.0; no trade levels (SKIP).
Past ratings for ONC
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 4, 2026 | SKIP | 6% | $355.00 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on ONC
- Nov 3, 2026: BeOne Medicines to Present at the Jefferies Global Healthcare Conference (Business Wire)
Other Healthcare stocks we cover
ORKA · OSCR · PCRX · PCVX · PEN · PFE · PGNY · PHG · PHR · PRGO · PTGX · QURE
Frequently asked questions
Is ONC a buy right now?
As of Nov 4, 2026, our automated model rates BeOne Medicines Ltd. (ONC) SKIP with 6% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does BeOne Medicines Ltd. report earnings next?
The next earnings report is expected around Nov 5, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.